SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OCATA THERAPEUTICS
OCAT 8.4700.0%Feb 11 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Savant3/15/2012 8:37:36 PM
   of 134
 
View: Annual Data | Quarterly Data All numbers in thousands
Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Period Ending
Total Revenue 66 133 154 154
Cost of Revenue 23 17 282 23
Gross Profit 43 116 (128) 131
Operating Expenses
Research Development 2,979 4,036 1,532 1,475
Selling General and Administrative 2,831 2,976 1,952 3,198
Non Recurring - - - -
Others - - - -
Total Operating Expenses - - - -
Operating Income or Loss (5,767) (6,896) (3,612) (4,836)
Income from Continuing Operations
Total Other Income/Expenses Net (6,063) (45,350) (936) 1,881
Earnings Before Interest And Taxes (11,830) (52,246) (4,548) (2,660)
Interest Expense 281 275 272 682
Income Before Tax (12,112) (52,521) (4,820) (3,342)
Income Tax Expense - - - -
Minority Interest - - - -
Net Income From Continuing Ops (12,112) (52,521) (4,820) (3,342)
Non-recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income (12,112) (52,521) (4,820) (3,342)
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares (12,112) (52,521) (4,820) (3,342)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext